Christopher L. Carpenter
Private Equity Investor bei Sofinnova Investments, Inc.
Profil
Christopher L.
Carpenter is currently an Executive Partner at Sofinnova Investments, Inc. and also serves as the Chief Medical Officer at Catamaran Bio, Inc. Previously, he held the position of Senior Vice President at GSK Plc from 2013 to 2017 and was the Chief Medical Officer at Rubius Therapeutics, Inc. from 2017 to 2020.
Carpenter received his undergraduate degree from Stanford University and his doctorate from the University of Southern California.
Aktive Positionen von Christopher L. Carpenter
| Unternehmen | Position | Beginn |
|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 03.01.2022 |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Christopher L. Carpenter
| Unternehmen | Position | Ende |
|---|---|---|
| RUBIUS THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 06.01.2020 |
| GSK PLC | Corporate Officer/Principal | 01.08.2017 |
Ausbildung von Christopher L. Carpenter
| University of Southern California | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Finance |
